Literature DB >> 30104727

Network changes associated with transdiagnostic depressive symptom improvement following cognitive behavioral therapy in MDD and PTSD.

Zhen Yang1, Shi Gu2,3, Nicolas Honnorat4, Kristin A Linn1,5, Russell T Shinohara1,5, Irem Aselcioglu1, Steven Bruce1,2,6, Desmond J Oathes1, Christos Davatzikos4, Theodore D Satterthwaite1,3, Danielle S Bassett2,7,8, Yvette I Sheline9,10,11.   

Abstract

Despite widespread use of cognitive behavioral therapy (CBT) in clinical practice, its mechanisms with respect to brain networks remain sparsely described. In this study, we applied tools from graph theory and network science to better understand the transdiagnostic neural mechanisms of this treatment for depression. A sample of 64 subjects was included in a study of network dynamics: 33 patients (15 MDD, 18 PTSD) received longitudinal fMRI resting state scans before and after 12 weeks of CBT. Depression severity was rated on the Montgomery-Asberg Depression Rating Scale (MADRS). Thirty-one healthy controls were included to determine baseline network roles. Univariate and multivariate regression analyses were conducted on the normalized change scores of within- and between-system connectivity and normalized change score of the MADRS. Penalized regression was used to select a sparse set of predictors in a data-driven manner. Univariate analyses showed greater symptom reduction was associated with an increased functional role of the Ventral Attention (VA) system as an incohesive provincial system (decreased between- and decreased within-system connectivity). Multivariate analyses selected between-system connectivity of the VA system as the most prominent feature associated with depression improvement. Observed VA system changes are interesting in light of brain controllability descriptions: attentional control systems, including the VA system, fall on the boundary between-network communities, and facilitate integration or segregation of diverse cognitive systems. Thus, increasing segregation of the VA system following CBT (decreased between-network connectivity) may result in less contribution of emotional attention to cognitive processes, thereby potentially improving cognitive control.

Entities:  

Mesh:

Year:  2018        PMID: 30104727     DOI: 10.1038/s41380-018-0201-7

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  12 in total

1.  Aberrant brain connectivity is associated with childhood maltreatment in individuals with major depressive disorder.

Authors:  Qianyi Luo; Juran Chen; Yuhong Li; Zhiyao Wu; Xinyi Lin; Jiazheng Yao; Huiwen Yu; Huawang Wu; Hongjun Peng
Journal:  Brain Imaging Behav       Date:  2022-07-29       Impact factor: 3.224

2.  Mapping Neural Circuit Biotypes to Symptoms and Behavioral Dimensions of Depression and Anxiety.

Authors:  Andrea N Goldstein-Piekarski; Tali M Ball; Zoe Samara; Brooke R Staveland; Arielle S Keller; Scott L Fleming; Katherine A Grisanzio; Bailey Holt-Gosselin; Patrick Stetz; Jun Ma; Leanne M Williams
Journal:  Biol Psychiatry       Date:  2021-07-11       Impact factor: 12.810

3.  A Pilot Study on Playback Theatre as a Therapeutic Aid after Natural Disasters: Brain Connectivity Mechanisms of Effects on Anxiety.

Authors:  Sarat Munjuluri; Peter K Bolin; Y T Amy Lin; Nina L Garcia; Leslie Gauna; Tien Nguyen; Ramiro Salas
Journal:  Chronic Stress (Thousand Oaks)       Date:  2020-11-03

4.  Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence.

Authors:  Agnes Norbury; Sarah B Rutter; Abigail B Collins; Sara Costi; Manish K Jha; Sarah R Horn; Marin Kautz; Morgan Corniquel; Katherine A Collins; Andrew M Glasgow; Jess Brallier; Lisa M Shin; Dennis S Charney; James W Murrough; Adriana Feder
Journal:  Neuropsychopharmacology       Date:  2021-07-31       Impact factor: 7.853

5.  Amygdala and Insula Connectivity Changes Following Psychotherapy for Posttraumatic Stress Disorder: A Randomized Clinical Trial.

Authors:  Gregory A Fonzo; Madeleine S Goodkind; Desmond J Oathes; Yevgeniya V Zaiko; Meredith Harvey; Kathy K Peng; M Elizabeth Weiss; Allison L Thompson; Sanno E Zack; Steven E Lindley; Bruce A Arnow; Booil Jo; Barbara O Rothbaum; Amit Etkin
Journal:  Biol Psychiatry       Date:  2020-12-08       Impact factor: 13.382

6.  Childhood trauma history is linked to abnormal brain connectivity in major depression.

Authors:  Meichen Yu; Kristin A Linn; Russell T Shinohara; Desmond J Oathes; Philip A Cook; Romain Duprat; Tyler M Moore; Maria A Oquendo; Mary L Phillips; Melvin McInnis; Maurizio Fava; Madhukar H Trivedi; Patrick McGrath; Ramin Parsey; Myrna M Weissman; Yvette I Sheline
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

7.  A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants.

Authors:  Samaneh Nemati; Teddy J Akiki; Jeremy Roscoe; Yumeng Ju; Christopher L Averill; Samar Fouda; Arpan Dutta; Shane McKie; John H Krystal; J F William Deakin; Lynnette A Averill; Chadi G Abdallah
Journal:  iScience       Date:  2019-12-23

8.  Brain Networks Connectivity in Mild to Moderate Depression: Resting State fMRI Study with Implications to Nonpharmacological Treatment.

Authors:  Dmitry D Bezmaternykh; Mikhail Ye Melnikov; Andrey A Savelov; Lyudmila I Kozlova; Evgeniy D Petrovskiy; Kira A Natarova; Mark B Shtark
Journal:  Neural Plast       Date:  2021-01-15       Impact factor: 3.599

9.  Does trauma-focused psychotherapy change the brain? A systematic review of neural correlates of therapeutic gains in PTSD.

Authors:  Antje Manthey; Anika Sierk; Eva-Lotta Brakemeier; Henrik Walter; Judith K Daniels
Journal:  Eur J Psychotraumatol       Date:  2021-08-06

10.  Ginsenoside Rg1 Prevents PTSD-Like Behaviors in Mice Through Promoting Synaptic Proteins, Reducing Kir4.1 and TNF-α in the Hippocampus.

Authors:  Zhengrong Zhang; Zhujin Song; Fengming Shen; Pan Xie; Juan Wang; Ai-Song Zhu; Guoqi Zhu
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.